MTOR and glioblastoma: This is of particular interest to Glioblastoma, as in 88% of all glioma genetic alterations have been found in the PI3-Kinase/Akt/mTOR network [8, 9], a signaling cascade for which a multitude of pharmacological inhibitors are currently on the market [10].